CALZINC
Natural health product licensed in Canada
- Other names
- Neobourne Pharma Calcium 500 & Zinc, ZINC-CAL 500
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80021880
- Status
- Inactive licence
- Licence date
- 25 October 2010
- Revision date
- 17 May 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 49.98 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 49.98 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 16.66 mg | 49,980 µg |
Non-medicinal ingredients
Stéarate de magnésium, Bleu brilliant FCF, Cire de Carnauba, Dioxyde de titanium, Eau, Croscarmellose de sodium, Talc, Dioxyde de silicium, Alcool isopropylique, Jaune D&C No. 10, Macrogol 8000, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Aide au développement et au maintien des os et des dents. La consommation du calcium, lorsqu'elle s'accompagne d'un apport suffisant en vitamine D, d'une alimentation saine et de la pratique régulière d'une activité physique, peut réduire le risque d'ostéoporose. Aide à prévenir une carence en calcium. Aide l'organisme à métaboliser les glucides (hydrates de carbone), les lipides et les protéines. Aide à la formation de tissus conjonctifs. Aide au maintien des fonctions immunitaires.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Garder hors de la portée des enfants. Conserver dans un endroit frais et sec.
Source
Official Health Canada record, licence 80021880
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging